Claritev Corporation logo

Claritev Corporation (CTEV)

Market Open
1 Sep, 18:37
NYSE NYSE
$
40. 07
+0.24
+0.6026%
$
671.51M Market Cap
- P/E Ratio
- Div Yield
58,026 Volume
- Eps
$ 39.83
Previous Close
Add Transaction
Day Range
38.83 40.82
Year Range
11.5 74.07
Want to track CTEV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CTEV trading today higher at $40.07, an increase of 0.6026% from yesterday's close, completing a monthly increase of 74.9018% or $17.16. Over the past 12 months, CTEV stock lost -6.9006%.
CTEV is not paying dividends to its shareholders.
The last earnings report, released on May 06, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -2.1097%, based on the last three reports.
Claritev Corporation has completed 1 stock splits, with the recent split occurring on Sep 23, 2024.
The company's stock is traded on one exchange.

CTEV Chart

People also search for

CXM
Sprinklr Inc.
$ 7.63
-7.0646%
DXC
Dxc Technology Co.
$ 11.08
-1.9469%
Globant S.A.
$ 39.7
-2.481%
AI
C3.ai Inc.
$ 10.21
-5.5915%
PRG
Prog Holdings Inc.
$ 37.51
-1.626%
Claritev Q2 Earnings Call Highlights

Claritev Q2 Earnings Call Highlights

Claritev NYSE: CTEV reported second-quarter revenue growth, record bookings and higher cash flow, prompting the healthcare technology company to raise its full-year revenue, adjusted EBITDA and free-cash-flow outlook.

Marketbeat | 3 weeks ago
Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript

Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript

Claritev Corporation (CTEV) Q2 2026 Earnings Call Transcript

Seekingalpha | 3 weeks ago
Claritev Corporation (CTEV) Reports Q2 Loss, Tops Revenue Estimates

Claritev Corporation (CTEV) Reports Q2 Loss, Tops Revenue Estimates

Claritev Corporation (CTEV) came out with a quarterly loss of $3.49 per share versus the Zacks Consensus Estimate of a loss of $4.1. This compares to earnings of $0.32 per share a year ago.

Zacks | 3 weeks ago

Claritev Corporation Investors

Name Quantity Cost Value Profit ($) Gain (%)
Curtis Ellergodt
Curtis Ellergodt Rothschild Investment LLC
7 $167.43 $158.97 -$8.46 -5.05%
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
10 $76.4 $349.6 $273.2 357.59%
KL
Kahyeong Lee Oak Hill Advisors LP
91,773 $862,727.62 $3.5M $2.64M 305.5%
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
39,000 $1.11M $1.49M $380,035 34.34%
Jeff Ameen
Jeff Ameen Spire Wealth Management
140 $5,985 $3,179.4 -$2,805.6 -46.88%

Claritev Corporation (CTEV) FAQ

What is the stock price today?

The current price is $40.07.

On which exchange is it traded?

Claritev Corporation is listed on NYSE.

What is its stock symbol?

The ticker symbol is CTEV.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 671.51M.

Has Claritev Corporation ever had a stock split?

Claritev Corporation had 1 splits and the recent split was on Sep 23, 2024.

Claritev Corporation Profile

Software Industry
Information Technology Sector
Travis S. Dalton CEO
NYSE Exchange
62548M209 CUSIP
US Country
3,000 Employees
- Last Dividend
23 Sep 2024 Last Split
- IPO Date

Overview

Claritev Corporation, along with its subsidiaries, is a provider of innovative data analytics and technology-enabled solutions focused on cost management, payment, and revenue integrity specifically tailored for the healthcare industry in the United States. The company is dedicated to offering analytics-based services aimed at reducing medical expenses by utilizing data-driven algorithms that effectively detect claims overcharges and facilitate negotiation or reimbursement recommendations. Additionally, Claritev Corporation enhances cost management through network-based services that offer contracted discounts with healthcare providers, along with comprehensive outsourced network development and management services.

Founded in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before changing its name in February 2025. The company serves various clients including national and regional insurance entities, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review organizations, and other stakeholders involved in the claims adjudication process.

Products and Services

  • Analytics-Based Services:

    These services leverage sophisticated data-driven algorithms and insights to detect overcharges in medical claims. By negotiating or recommending appropriate reimbursement amounts, Claritev helps reduce unnecessary healthcare costs.

  • Network-Based Services:

    Claritev provides contracted discounts with healthcare providers. These services also include outsourced network development and management to optimize provider collaboration and payment efficiencies.

  • Payment and Revenue Integrity Services:

    This suite involves identifying and eliminating improper and unnecessary charges that may have been incurred during the claims process. The company also focuses on recognizing underpaid premium dollars to ensure clients receive owed amounts.

  • Data and Decision Science Services:

    Claritev employs modern data science methodologies to deliver descriptive, predictive, and prescriptive analytics. This helps in designing optimized benefit plans, supports informed decision-making, improves clinical outcomes, and reduces overall care costs.

  • Business-to-Business Healthcare Payments:

    The company offers various services related to healthcare payments between businesses, streamlining financial transactions in the healthcare ecosystem while maintaining compliance and integrity.

Contact Information

Address: 7900 Tysons One Place
Phone: (212) 780-2000